What a truly monumental day for RAC and holders. Congratulations to the RAC team for accomplishing something that all others had previously failed. With this, the entire solid tumor opportunity is now within reach. CPACS is now ours to go after and generations of cancer patients treated with anthracyclines et al. will benefit from a lack of heart toxicity in the future.
How refreshing it is to see milestones delivered on time and on budget. My confidence with RAC has never been higher which is incredible given it had never been lower less than 12 months ago.
I really enjoyed reading the Q&A in this announcement. Looking forward to seeing the first patient dosed by the end of this year hopefully!
Ann: RC220 GLP Non-clinical Toxicology Program Successful, page-20
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
